TITLE

Review: Some therapies for treating the irritable bowel syndrome may be effective for symptom improvement

PUB. DATE
May 2005
SOURCE
ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p78
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents information related to therapies for treating the irritable bowel syndrome (IBS) which may be effective for symptom improvement. Fully published studies in the English language were selected if they were placebo-controlled studies on the treatment of IBS. 5 trials showed a benefit of alosetron for relieving IBS symptoms in patients with diarrhea only. 4 trials showed a benefit of tegaserod for relieving IBS symptoms in patients with constipation, but the studies were mainly done in women.
ACCESSION #
17116550

 

Related Articles

  • FUNCTIONAL BOWEL DISORDERS.  // American Journal of Gastroenterology;Sep2005 Supplement 2, Vol. 100, pS321 

    The article presents abstracts of research papers related to functional bowel disorders. They include "The Prevalence of Constipation in Korean Population," "Cyclic Vomiting Syndrome in Adults: A Report of 41 Patients," "Visual Feedback Alters Perception of Rectal Distension in Patients with...

  • Treatment of Diarrhea-Predominant Irritable Bowel Syndrome with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Trial. Leung, Wai K.; Wu, Justin C.Y.; Liang, S.M.; Chan, L.S.; Chan, Francis K.L.; He Xie; Fung, Sara S.L.; Hui, Aric J.; Wong, Vincent W.S.; Chun-Tao Che; Sung, Joseph J.Y. // American Journal of Gastroenterology;Jul2006, Vol. 101 Issue 7, p1574 

    BACKGROUND: As there is no effective treatment for irritable bowel syndrome (IBS), many patients turn to traditional Chinese medicine (TCM) for possible cure. We investigated the therapeutic efficacy of an ancient herbal Chinese formula in patients with diarrhea-predominant IBS. METHODS: This...

  • Effect of CCK-1 Antagonist, Dexloxiglumide, in Female Patients with Irritable Bowel Syndrome: A Pharmacodynamic and Pharmacogenomic Study. Cremonini, Filippo; Camilleri, Michael; McKinzie, Sanna; Carlson, Paula; Camilleri, Christopher E.; Burton, Duane; Thomforde, George; Urrutia, Raul; Zinsmeister, Alan R. // American Journal of Gastroenterology;Mar2005, Vol. 100 Issue 3, p652 

    BACKGROUND: Cholecystokinin (CCK) is involved in gastrointestinal motor response to meals. The potential role of CCK receptor antagonists in functional gastrointestinal disorders is unclear.AIMS: To evaluate the effects of dexloxiglumide, a CCK-1 receptor antagonist, on gastrointestinal transit...

  • A Dose-Ranging, Phase II Study of the Efficacy and Safety of Alosetron in Men with Diarrhea-Predominant IBS. Chang, Lin; Ameen, Vanessa Z.; Dukes, George E.; McSorley, David J.; Carter, Eric G.; Mayer, Emeran A. // American Journal of Gastroenterology;Jan2005, Vol. 100 Issue 1, p115 

    BACKGROUND: A randomized, double blind, placebo-controlled dose-ranging study was conducted to assess the efficacy of alosetron in men with diarrhea-predominant irritable bowel syndrome (IBS).METHODS: Six hundred and sixty-two men were randomized to treatment with alosetron 0.5, 1.0, 2.0, 4.0...

  • Neurogastroenterology/motility free papers.  // Gut;Apr2005 Supplement 2, Vol. 54, pA18 

    The article presents information on abstracts related to neurogastroenterology. According to an abstract cilansetron is efficacious in relieving bowel habit related symptoms in irritable bowel syndrome with diarrhoea predominance. Diarrhoea and abdominal pain/discomfort are key symptoms of...

  • Psyllium Therapy in the Irritable Bowel Syndrome. Longstreth, George F.; Fox, David D.; Youkeles, Lee; Forsythe, Alan B.; Wolochow, Donald A. // Annals of Internal Medicine;Jul81, Vol. 95 Issue 1, p53 

    Presents a study that conducted a randomized, double-blind trial of therapy with a psyllium preparation in patients with painful irritable bowel syndrome. Comparison of diary data during baseline and treatment periods for patients on psyllium and those on placebo; Influence of personality...

  • CLINICAL EVALUATION OF AN ANTICHOLINERGIC IN THE IRRITABLE COLON SYNDROME. Kasich, Anthony M.; Rafsky, Jeanne C. // American Journal of Gastroenterology;Jan1959, Vol. 31 Issue 1, p47 

    The effects of tricyclamol, tricyclamol with phenobarbital, phenobarbital, and a placebo, were studied in patients with irritable colon by the double blind method. The average duration of treatment was one month. The patients were asked to note the effect on gastric distress, bloatedness,...

  • Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. Kaptchuk, Ted J.; Kelley, John M.; Conboy, Lisa A.; Davis, Roger B.; Kerr, Catherine E.; Jacobson, Eric E.; Kirsch, Irving; Schyner, Rosa N.; Bong Hyun Nam; Long T. Nguyen; Min Park; Rivers, Andrea L.; McManus, Claire; Kokkotou, Efi; Drossman, Douglas A.; Goldman, Peter; Lembo, Anthony J. // BMJ: British Medical Journal (International Edition);5/3/2008, Vol. 336 Issue 7651, p999 

    Objective To investigate whether placebo effects can experimentally be separated into the response to three components; assessment and observation, a therapeutic ritual (placebo treatment), and a supportive patient-practitioner relationship, and then progressively combined to produce incremental...

  • Ondansetron and irritable bowel syndrome. Luthra, Pavit; Ford, Alexander C. // Gut;Jul2015, Vol. 64 Issue 7, p1181 

    The article discusses a study conducted to test the efficacy of drug Ondansetron in the treatment of irritable bowel syndrome. It mentions that the drug achieved greater results when compared to a placebo in the treatment of pain and stool response. It suggests that placebo response rates,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics